Key Points
- This research aims to assess the differences between population-based and individual-based therapeutic goals in antihypertensive treatment.
- Analysis of population studies and clinical trial data relating to blood pressure and cardiovascular risk.
- Evaluation of thresholds for blood pressure reduction and its effects on different patient populations.
- Discussion of treatment customization based on patient history, risk factors, and comorbidities.
- Increased cardiovascular risk is noted when blood pressure exceeds 115/75 mm Hg.
- Each increment of 20 mm Hg in systolic BP and 10 mm Hg in diastolic BP doubles the risk of complications.
- Patients with diabetes or proteinuria require more aggressive blood pressure management to mitigate risks.
Structured PICO
PPopulationPatients with hypertension
IInterventionAntihypertensive treatment
OOutcomeCardiovascular complications (coronary heart disease, stroke, heart failure, and renal failure)
Treatment decisions for hypertension should be tailored to individual patients, integrating history, risk, pathophysiology, and lifestyle, rather than relying solely on population-based targets.
Limitations
- Application of clinical trial results to individual patients is limited by the heterogeneity of patient populations with respect to patient risk, comorbidities, and differences in genetic and environmental background.